110
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Sevoflurane reduces ischemic brain injury in rats with diet and streptozotocin-induced diabetes

, , , &
Pages 448-454 | Received 10 Sep 2018, Accepted 22 Jan 2019, Published online: 30 Apr 2019

References

  • Venketasubramanian N, Yoon BW, Pandian J, et al. Stroke Epidemiology in South, East, and South-East Asia: a review. J Stroke. 2017;19:286–294.
  • Zhang X, Qi X, Yoshida EM, et al. Ischemic stroke in liver cirrhosis: epidemiology, risk factors, and in-hospital outcomes. Eur J Gastroenterol Hepatol. 2018;30:233–240.
  • Zhang Y, Jiang X, Bo J, et al. Investigators, risk of stroke and coronary heart disease among various levels of blood pressure in diabetic and nondiabetic Chinese patients. J Hypertens. 2018;36:93–100.
  • Osei E, Fonville S, Zandbergen AA, et al. Glucose in prediabetic and diabetic range and outcome after stroke. Acta Neurol Scand. 2017;135:170–175.
  • Muñoz-Rivas N, Méndez-Bailón M, Hernández-Barrera V, et al. Time trends in ischemic stroke among type 2 diabetic and non-diabetic patients: analysis of the Spanish National Hospital Discharge Data (2003-2012). PLoS One. 2015;10:e0145535.
  • Wang HY, Wang GL, Yu YH, et al. The role of phosphoinositide-3-kinase/Akt pathway in propofol-induced postconditioning against focal cerebral ischemia-reperfusion injury in rats. Brain Res. 2009;1297:177–184.
  • Luo Y, Ma D, Ieong E, et al. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology. 2008;109:782–789.
  • Sakai H, Sheng H, Yates RB, et al. Isoflurane provides long-term protection against focal cerebral ischemia in the rat. Anesthesiology. 2007;106:92–99.
  • Adamczyk S, Robin E, Simerabet M, et al. Sevoflurane pre- and post-conditioning protect the brain via the mitochondrial K ATP channel. Br J Anaesth. 2010;104:191–200.
  • Wang JK, Yu LN, Zhang FJ, et al. Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res. 2010;1357:142–151.
  • Pérez-Asensio FJ, Hurtado O, Burguete MC, et al. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia. Neurobiol Dis. 2005;18:375–384.
  • Murphy TH, Li P, Betts K, et al. Two-photon imaging of stroke onset in vivo reveals that NMDA-receptor independent ischemic depolarization is the major cause of rapid reversible damage to dendrites and spines. J Neurosci. 2008;28:1756–1772.
  • Zhao H, Yenari MA, Cheng D, et al. Steinberg, Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem. 2003;85:1026–1036.
  • Chen W, Sun Y, Liu K, et al. Autophagy: a double-edged sword for neuronal survival after cerebral ischemia. Neural Regen Res. 2014;9:1210–1216.
  • Gupta R, Ghosh S. Putative roles of mitochondrial Voltage-Dependent Anion Channel, Bcl-2 family proteins and c-Jun N-terminal Kinases in ischemic stroke associated apoptosis. Biochim Open. 2017;4:47–55.
  • Armstead WM, Hekierski H, Yarovoi S, et al. tPA variant tPA-A(296-299) Prevents impairment of cerebral autoregulation and necrosis of hippocampal neurons after stroke by inhibiting upregulation of ET-1. J Neuro Res. 2018;96:128–137.
  • Diaz-Morales N, Rovira-Llopis S, Escribano-Lopez I, et al. Role of oxidative stress and mitochondrial dysfunction in skeletal muscle in type 2 diabetic patients. Cpd. 2016;22:2650–2656.
  • Romero-Nava R, Rodriguez JE, Reséndiz-Albor AA, et al. Changes in protein and gene expression of angiotensin II receptors (AT1 and AT2) in aorta of diabetic and hypertensive rats. Clin Exp Hypertens. 2016;38:56–62.
  • Sorci G, Riuzzi F, Arcuri C, et al. S100B protein in tissue development, repair and regeneration. World J Biol Chem. 2013;4:1–12.
  • Steiner J, Bogerts B, Schroeter ML, et al. S100B protein in neurodegenerative disorders. Clin Chem Lab Med. 2011;49:409–424.
  • Fragoso-Loyo H, Cabiedes J, Atisha-Fregoso Y, et al. Utility of serum S100B protein for identification of central nervous system involvement in systemic lupus erythematosus. J Rheumatol. 2010;37:2280–2285.
  • Rodríguez-Rodríguez A, Egea-Guerrero JJ, León-Justel A, et al. Role of S100B protein in urine and serum as an early predictor of mortality after severe traumatic brain injury in adults. Clin Chim Acta. 2012;414:228–233.
  • Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84–91.
  • Reynolds A, Laurie C, Mosley RL, et al. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol. 2007;82:297–325.
  • Ahmed E, Donovan T, Yujiao L, et al. Mitochondrial Targeted Antioxidant in Cerebral Ischemia. J Neurol Neurosci 2015;6.
  • Djordjevic A, Spasic S, Jovanovic-Galovic A, et al. Oxidative stress in diabetic pregnancy: SOD, CAT and GSH-Px activity and lipid peroxidation products. J Matern Fetal Neonatal Med. 2004;16:367–372.
  • Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke 2009;40:e331–e339.
  • Wang Y, Li X, Wang X, et al. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3beta signaling and inhibition of the mitochondria-dependent apoptotic pathway. PLoS One. 2013;8:e70956.
  • Yao K, Ye P, Zhang L, et al. Epigallocatechin gallate protects against oxidative stress-induced mitochondria-dependent apoptosis in human lens epithelial cells. Mol Vis. 2008;14:217–223.
  • Cook SA, Sugden PH, Clerk A. Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res. 1999;85:940–949.
  • Zhou S, Bao J, Wang Y, et al. S100beta as a biomarker for differential diagnosis of intracerebral hemorrhage and ischemic stroke. Neurol Res. 2016;38:327–332.
  • Purrucker JC, Herrmann O, Lutsch JK, et al. Serum protein S100beta is a diagnostic biomarker for distinguishing posterior circulation stroke from vertigo of nonvascular causes. Eur Neurol. 2014;72:278–284.
  • Dassan P, Keir G, Brown MM. Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc Dis. 2009;27:295–302.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.